The serodiagnosis of Lyme borreliosis is based on a two-tier strategy: a screening test using
an immunoenzymatic technique (ELISA), followed if positive by a confirmatory test with a …

Lyme borreliosis is transmitted en France by the tick Ixodes ricinus, endemic in metropolitan
France. In the absence of vaccine licensed for use in humans, primary prevention mostly …

Lyme borreliosis is a tick-borne disease that predominantly occurs in temperate regions of
the northern hemisphere and is primarily caused by the bacterium Borrelia burgdorferi in …

Lyme borreliosis is caused by certain genospecies of the Borrelia burgdorferi sensu lato
complex, which are transmitted by hard ticks of the genus Ixodes. The most common clinical …

Physicians and biologists from different backgrounds have contributed to this volume which
provides a unique state-of-the-art approach to all aspects of Lyme borreliosis. From the …

Chemoprophylaxis is a term which describes treatment with an antimicrobial
chemotherapeutic before, during or shortly after an actual or suspected exposure to an …

Background Lyme disease is the most frequent tick-borne infectious disease in Europe. The
discovery of the causative pathogen Borrelia burgdorferi in 1982 opened the way for the firm …

Lyme borreliosis is a tick-borne infectious disease caused by the spirochaetes Borrelia
burgdorferi, B. garinii and B. afzelii. It comprises a wide spectrum of symptoms affecting skin …

Widespread awareness of Lyme borreliosis in Europe continues to grow due to increasing
numbers of medical publications, information on the Internet, and from the media and patient …

Since very little is known about the clinical expression of Lyme borreliosis in Western
Europe, a 3-year prospective study was conducted that included all patients seen for …